![Steven Brugger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Steven Brugger
Keine laufenden Positionen mehr
Profil
Steven B. Brugger was the founder of Affinivax, Inc., founded in 2014, where the titles held included President, Chief Executive Officer & Director.
Former jobs include Chief Executive Officer & Director at Visterra, Inc. from 2012 to 2013, Executive Director-Marketing at Novartis Pharmaceuticals Corp., Vice President at Millennium Pharmaceuticals, Inc. from 1999 to 2002, Chief Operating Officer at Momenta Pharmaceuticals, Inc. from 2002 to 2010, General Manager-Inflammation & Metabolic Business at Aventis, Inc., General Manager-Inflammation & Metabolic Business at Abbott Diagnostics, Inc., and President & Chief Operating Officer at Strategic Science & Technologies LLC.
Education includes an MBA from Rutgers State University of New Jersey and an undergraduate degree from Susquehanna University.
Ehemalige bekannte Positionen von Steven Brugger
| Unternehmen | Position | Ende |
|---|---|---|
| VISTERRA INC | Präsident | 15.07.2013 |
| MOMENTA PHARMACEUTICALS, INC. | Geschäftsführer | 05.11.2010 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | 01.08.2002 |
Affinivax, Inc.
 Affinivax, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops novel conjugation technology | Gründer | - |
Strategic Science & Technologies LLC
 Strategic Science & Technologies LLC Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company which develops and distributes pharmaceutical products | Präsident | - |
Ausbildung von Steven Brugger
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
73
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that discovers and develops novel biologic therapies for the treatment of rare immune-mediated diseases | Health Technology |
Aventis, Inc.
 Aventis, Inc. MiscellaneousMiscellaneous Functions as an investment holding company | Miscellaneous |
Strategic Science & Technologies LLC
Strategic Science & Technologies LLC Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company which develops and distributes pharmaceutical products | Health Technology |
Visterra, Inc.
 Visterra, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Susquehanna University
 Susquehanna University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Abbott Diagnostics, Inc.
 Abbott Diagnostics, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and sells medical diagnostic instrument, test and automation products | Health Technology |
Affinivax, Inc.
Affinivax, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops novel conjugation technology | Health Technology |
